ClinicalTrials.govpublic full text
Safety and Immunogenicity of the Recombinant Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 18 Years and Older
respiratory syncytial virus infection
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 146287
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.